BenevolentAI has raised $205M across 2 funding rounds, plus 1 undated round. The company is valued at $2B (pre-money).
BenevolentAI is publicly traded on Euronext Amsterdam under the ticker BAI. In 2023 the company reduced spending and freed up £45 million of net cash to increase its financial flexibility, extending its cash runway to at least July 2025.
2 funding rounds, the latest highlighted.
BenevolentAI was founded in 2014, United Kingdom.
No date is disclosed for this round.
A primary round — the company sells new shares to investors it selects. $115M raised, led by Existing investors.
No filing has been made.
2 dated rounds, newest first.
TemasekLEADEExisting investorsLEADMMultiple institutional investorsNo. BenevolentAI is a private company; its shares do not trade on a public exchange.
The last valuation is $2B.
Lead investors for each round are in the funding timeline.
The closest biotechnology/ai peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
